Results 271 to 280 of about 199,474 (298)
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
Effect of low dose azithromycin on the fecal microbiome and fecal bile acids in healthy dogs. [PDF]
Smith C +5 more
europepmc +1 more source
Gut microbiota dysbiosis and the gut-lung axis in COPD: mechanisms, clinical relevance, and microbiota-targeted interventions. [PDF]
Chai Y +8 more
europepmc +1 more source
Commensal Dysbiosis Alters Primary Bile Acid Signaling to Drive Mammary Gland Inflammation and Breast Tumor Dissemination. [PDF]
Putelo AM +17 more
europepmc +1 more source
Gut microbiota-host immunity crosstalk in psoriasis: from dysbiosis to cutaneous inflammation. [PDF]
Zhang M, Zhang S, Ren X.
europepmc +1 more source
Cognitive-Behavioural Correlates of Dysbiosis: A Review
Evidence suggests an association between an altered gut microbiota (dysbiosis), cognitive performance and behaviour. This paper provides an overview of the current literature regarding the cognitive-behavioural correlates of dysbiosis, with special ...
Maria Luca, Antonina Luca
exaly +2 more sources
The global health impact of vaginal dysbiosis [PDF]
The most common dysbiosis of the vaginal microbiome (defined here as a vaginal microbiome not dominated by lactobacilli) is bacterial vaginosis, an anaerobic polybacterial dysbiosis.
Vicky Jespers, Janneke van de Wijgert
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn
Gut, 2021Objective Stroke is a leading cause of death and disability worldwide. Neuroprotective approaches have failed in clinical trials, thus warranting therapeutic innovations with alternative targets.
Kaiyu Xu +18 more
semanticscholar +1 more source

